Researchers uncover key to combat Campylobacter infections

Bacterial infections resulting in enteritis, sometimes extra-intestinal infections such as sepsis, continue to be a global health concern.

Why Novartis is going to walk away from its acquisition of MorphoSys

Novartis said Monday that it intends to buy MorphoSys for just under $3 billion. The deal will not close. Six months from now, or sooner,

February 6, 2024

Risk Adjusted Net Present Value: What is the current valuation of Disc Medicine’s DISC-0974

The revenue for DISC-0974 is expected to reach an annual total of $98 mn by 2038 in the US based off GlobalData’s Expiry Model. The

November 4, 2023

Steward Health Care CEO Ralph de la Torre will resign

Dr. Ralph de la Torre, a former heart surgeon who built and became the face of Steward Health Care and its network of neglected hospitals, is stepping down

September 29, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.